Advances in Skin Cancer: Diagnosis, Treatment and Prognosis
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 160
Special Issue Editors
Interests: skin cancer; melanoma; basal cell carcinoma; cutaneous squamous cell carcinoma; dermoscopy; screening; dermatology–oncology; immunotherapy; targeted therapy
Interests: dermato-oncology; melanoma; non-melanoma skin cancer; noninvasive skin imaging; dermoscopy; super-high magnification dermoscopy; basal cell carcinoma; cutaneous squamous cell carcinoma; photodynamic therapy; targeted therapy; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Skin cancers are the most common forms of tumor, and their incidence has been increasing over the past few decades. They are generally classified as melanoma and non-melanoma skin cancers (NMSCs), including basal cell carcinoma, cutaneous squamous cell carcinoma, Merkel cell carcinoma, cutaneous lymphomas, adnexal tumors, and other rare primary skin tumors.
Most skin cancers can be cured if detected and treated early, with a survival rate higher than 95%.
Recently, there has been significant progress in the diagnosis and treatment of these tumors.
A wide variety of noninvasive optical technologies have been shown to increase diagnostic accuracy and aid in the management of skin cancers in recent years. This improvement in technology, along with advances in research and therapy, has helped improve the prognosis of patients with advanced disease.
This Special Issue aims to expand our knowledge on the recent advances in the diagnosis, treatment, and prognosis of skin cancers. Original research articles, reviews, case series, letters and commentary are welcome.
We look forward to receiving your contributions.
Dr. Iris Zalaudek
Dr. Roberta Giuffrida
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- skin cancer
- melanoma
- basal cell carcinoma
- cutaneous squamous cell carcinoma
- diagnosis
- noninvasive imaging
- therapy
- prognosis
- immunotherapy
- targeted therapy
